What Neos Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hecht Beth | Director | Mar 19 | Disposition to Issuer · D | −23,453 | — | — | 0 |
| Robinson James A. Jr. | Director | Mar 19 | Disposition to Issuer · D | −23,453 | — | — | 0 |
| Schmid John P. | Director | Mar 19 | Disposition to Issuer · D | −23,453 | — | — | 0 |
| McLaughlin Gerald W. | Chief Executive Officer | Mar 19 | Disposition to Issuer · D | −270,171 | — | — | 0 |
| Heller Alan L | Director | Mar 19 | Disposition to Issuer · D | −446,819 | — | — | 0 |
| Robitaille Gregory J | Director | Mar 19 | Disposition to Issuer · D | −79,130 | — | — | 0 |
| Fong Bryant | Director | Mar 19 | Disposition to Issuer · D | −24,953 | — | — | 0 |
| Eisenstadt Richard I | Chief Financial Officer | Mar 19 | Disposition to Issuer · D | −126,245 | — | — | 0 |
| Szyper Linda M | Director | Mar 19 | Disposition to Issuer · D | −23,453 | — | — | 0 |
| Limongelli John M | SVP & General Counsel | Mar 19 | Disposition to Issuer · D | −83,015 | — | — | 0 |
| McLaughlin Gerald W. | Chief Executive Officer | Mar 02 | Withheld — tax / exercise cost · F | −44,329 | $0.84 | −$37.4K | 270,171 |
| Eisenstadt Richard I | Chief Financial Officer | Mar 02 | Withheld — tax / exercise cost · F | −14,825 | $0.84 | −$12.5K | 126,245 |
| Limongelli John M | SVP & General Counsel | Mar 02 | Withheld — tax / exercise cost · F | −16,985 | $0.84 | −$14.3K | 83,015 |
| Eisenstadt Richard I | Chief Financial Officer | Mar 01 | Withheld — tax / exercise cost · F | −1,390 | $0.88 | −$1.23K | 141,070 |
| Robinson James A. Jr. | Director | Jun 10 | Grant / award · A | +23,453 | — | — | 23,453 |
| Hecht Beth | Director | Jun 10 | Grant / award · A | +23,453 | — | — | 23,453 |
| Schmid John P. | Director | Jun 10 | Grant / award · A | +23,453 | — | — | 23,453 |
| Fong Bryant | Director | Jun 10 | Grant / award · A | +23,453 | — | — | 24,953 |
| Robitaille Gregory J | Director | Jun 10 | Grant / award · A | +23,453 | — | — | 79,130 |
| Heller Alan L | Director | Jun 10 | Grant / award · A | +23,453 | — | — | 446,819 |
Loading...